test

Kevin Tang

@Tang Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.

Assets under management

The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
0.46%
$6.396M
400,000 shares@ $15.99 avg price
OMICSingular Genomics Systems In
Recent Activity
New Position
0.42%
$5.829M
372,000 shares@ $15.67 avg price
NUVLNuvalent Inc
Recent Activity
New Position
0.37%
$5.115M
50,000 shares@ $102.3 avg price
ALMSAlumis Inc
Recent Activity
New Position
0.33%
$4.556M
426,594 shares@ $10.69 avg price
SNYSanofi
Recent Activity
New Position
0.29%
$4.034M
70,000 shares@ $57.63 avg price
CYBNCybin Inc
Recent Activity
New Position
0.26%
$3.556M
400,000 shares@ $8.89 avg price
CMPXCompass Therapeutics Inc
Recent Activity
New Position
0.24%
$3.336M
1.813M shares@ $1.85 avg price
KZRKezar Life Sciences Inc
Recent Activity
New Position
0.21%
$2.815M
3.64M shares@ $0.78 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
New Position
0.17%
$2.379M
74,265 shares@ $32.05 avg price
TBPHTheravance Biopharma Inc
Recent Activity
New Position
0.16%
$2.119M
262,896 shares@ $8.07 avg price